Sneddon W Bruce, Syme Colin A, Bisello Alessandro, Magyar Clara E, Rochdi Moulay Driss, Parent Jean-Luc, Weinman Edward J, Abou-Samra Abdul B, Friedman Peter A
Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
J Biol Chem. 2003 Oct 31;278(44):43787-96. doi: 10.1074/jbc.M306019200. Epub 2003 Aug 14.
Parathyroid hormone (PTH) regulates extracellular calcium homeostasis through the type 1 PTH receptor (PTH1R) expressed in kidney and bone. The PTH1R undergoes beta-arrestin/dynamin-mediated endocytosis in response to the biologically active forms of PTH, PTH-(1-34), and PTH-(1-84). We now show that amino-truncated forms of PTH that do not activate the PTH1R nonetheless induce PTH1R internalization in a cell-specific pattern. Activation-independent PTH1R endocytosis proceeds through a distinct arrestin-independent mechanism that is operative in cells lacking the adaptor protein Na/H exchange regulatory factor 1 (NHERF1) (ezrin-binding protein 50). Using a combination of radioligand binding experiments and quantitative, live cell confocal microscopy of fluorescently tagged PTH1Rs, we show that in kidney distal tubule cells and rat osteosarcoma cells, which lack NHERF1, the synthetic antagonist PTH-(7-34) and naturally circulating PTH-(7-84) induce internalization of PTH1R in a beta-arrestin-independent but dynamin-dependent manner. Expression of NHERF1 in these cells inhibited antagonist-induced endocytosis. Conversely, expression of dominant-negative forms of NHERF1 conferred internalization sensitivity to PTH-(7-34) in cells expressing NHERF1. Mutation of the PTH1R PDZ-binding motif abrogated interaction of the receptor with NHERF1. These mutated receptors were fully functional but were now internalized in response to PTH-(7-34) even in NHERF1-expressing cells. Removing the NHERF1 ERM domain or inhibiting actin polymerization allowed otherwise inactive ligands to internalize the PTH1R. These results demonstrate that NHERF1 acts as a molecular switch that legislates the conditional efficacy of PTH fragments. Distinct endocytic pathways are determined by NHERF1 that are operative for the PTH1R in kidney and bone cells.
甲状旁腺激素(PTH)通过在肾脏和骨骼中表达的1型甲状旁腺激素受体(PTH1R)调节细胞外钙稳态。PTH1R会响应生物活性形式的PTH、PTH-(1-34)和PTH-(1-84),经历β-抑制蛋白/发动蛋白介导的内吞作用。我们现在表明,虽未激活PTH1R但截短氨基的PTH形式仍以细胞特异性模式诱导PTH1R内化。不依赖激活的PTH1R内吞作用通过一种独特的不依赖抑制蛋白的机制进行,该机制在缺乏衔接蛋白钠/氢交换调节因子1(NHERF1)(埃兹蛋白结合蛋白50)的细胞中起作用。通过放射性配体结合实验以及对荧光标记的PTH1R进行定量、活细胞共聚焦显微镜观察相结合,我们发现,在缺乏NHERF1的肾远曲小管细胞和大鼠骨肉瘤细胞中,合成拮抗剂PTH-(7-34)和天然循环的PTH-(7-84)以不依赖β-抑制蛋白但依赖发动蛋白的方式诱导PTH1R内化。在这些细胞中表达NHERF1可抑制拮抗剂诱导的内吞作用。相反,在表达NHERF1的细胞中,表达显性负性形式的NHERF1可使细胞对PTH-(7-34)产生内化敏感性。PTH1R的PDZ结合基序发生突变会消除该受体与NHERF1的相互作用。这些突变受体功能完全正常,但现在即使在表达NHERF1的细胞中也会因PTH-(7-34)而发生内化。去除NHERF1的ERM结构域或抑制肌动蛋白聚合可使原本无活性的配体促使PTH1R内化。这些结果表明,NHERF1作为一种分子开关,决定了PTH片段的条件性效力。NHERF1决定了不同的内吞途径,这些途径在肾和骨细胞中的PTH1R中起作用。